Suppr超能文献

足月引产时口服与阴道用米索前列醇的比较:一项随机对照试验。

Comparison of oral and vaginal misoprostol for induction of labor at term: a randomized controlled trial.

作者信息

Paungmora Nawarat, Herabutya Yongyoth, O-Prasertsawat Pratak, Punyavachira Piyaporn

机构信息

Department of Obstetrics and Gynecology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand.

出版信息

J Obstet Gynaecol Res. 2004 Oct;30(5):358-62. doi: 10.1111/j.1447-0756.2004.00215.x.

Abstract

OBJECTIVE

To compare the efficacy of oral with vaginal misoprostol for induction of labor at term.

METHODS

One hundred and fifty-three pregnant women at term with indications for induction of labor and Bishop score < or = 6 were randomly assigned to receive misoprostol either 100 microg orally or 50 microg vaginally every 6 h for 48 h. Repeated doses were given until Bishop score > or = 8 was achieved or spontaneous rupture of membranes occurred. Those who were not in labor after 48 h had labor induced with amniotomy and oxytocin. The main outcome measure was induction to delivery time.

RESULTS

The median induction to vaginal delivery time in the oral group (14.3 h) was not significantly different from that of the vaginal group (15.8 h). The median number of doses was also not significantly different in the oral group compared with the vaginal group. There was a significant higher incidence of uterine tachysystole in the vaginal group compared to the oral group (17.1% vs 5.3%, P = 0.032). There was no hyperstimulation in either group. There were no significant differences between the groups with respect to oxytocin augmentation, cesarean section rate, analgesic requirement, and neonatal outcomes.

CONCLUSION

Oral administration of 100 microg misoprostol has similar efficacy to intravaginal administration of 50 microg misoprostol for labor induction with less frequent abnormal uterine contractility. 100 microg of misoprostol orally can be used as an alternative to the vaginal route for labor induction.

摘要

目的

比较口服米索前列醇与阴道用米索前列醇足月引产的疗效。

方法

153例足月妊娠且有引产指征、Bishop评分≤6分的孕妇被随机分为两组,一组口服100μg米索前列醇,另一组阴道用50μg米索前列醇,均每6小时给药1次,共48小时。重复给药直至Bishop评分≥8分或胎膜自然破裂。48小时后仍未临产者行人工破膜及缩宫素引产。主要观察指标为引产至分娩时间。

结果

口服组引产至阴道分娩的中位时间(14.3小时)与阴道组(15.8小时)无显著差异。口服组与阴道组的中位给药次数也无显著差异。与口服组相比,阴道组子宫收缩过速的发生率显著更高(17.1%对5.3%,P = 0.032)。两组均无子宫过度刺激。两组在缩宫素加强宫缩、剖宫产率、镇痛需求及新生儿结局方面无显著差异。

结论

口服100μg米索前列醇与阴道用50μg米索前列醇引产疗效相似,但子宫异常收缩频率较低。100μg米索前列醇口服可作为引产的阴道给药途径的替代方法。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验